David G. Shand - Concepedia

Author

David G. Shand

Also Known As

D G Shand, D Shand, D. G. SHAND, D. G. Shand, D. Shand, D.G. SHAND, D.G. Shand, DAVID G. SHAND, David G Shand, David G. Shand

184

Publications

13.4K

Citations

H-Index

160

Concepts

All Affiliations

Vanderbilt University Duke Medical Center Duke University Vanderbilt University Medical Center

About

David G. Shand is an author at Vanderbilt University specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	74	7.1K
2	Health Sciences	17	19	1.3K
3	Public Health	3	3	371
4	Engineering	2	2	169
5	Natural Sciences	2	2	165

David G. Shand

115

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
A physiological approach to hepatic drug clearance G. Wilkinson, David G. Shand Clinical Pharmacology & Therapeutics	1975	1.9K
Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood Pressure David Robertson, Jürgen C. Frölich, R. Keith Carr, New England Journal of Medicine HypertensionPlasma Renin ActivityStudy CaffeineCardiovascular DiseaseSodium Homeostasis	1978	757
Reduced β‐adrenoceptor sensitivity in the elderly Robert E. Vestal, Alastair J.J. Wood, David G. Shand Clinical Pharmacology & Therapeutics Adrenal GlandFree PropranololAgingCardiovascular DiseaseGeriatrics	1979	621
Plasma propranolol levels in adults With observations in four children David G. Shand, E. M. Nuckolls, John A. Oates Clinical Pharmacology & Therapeutics HypertensionPharmacotherapyExperimental PharmacologyPharmacodynamic ModelingPre-clinical Pharmacology	1970	534
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. David L. Robertson, George Johnson, Rose Marie Robertson, Circulation NeuroendocrinologyAdrenal GlandExerciseSympathetic Nervous SystemNeuroendocrine Mechanism	1979	465
Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. A Rane, G. Wilkinson, David G. Shand Journal of Pharmacology and Experimental Therapeutics	1977	326
Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man D J Coltart, David G. Shand BMJ	1970	295
The Disposition of Propranolol David G. Shand, Robert E. Rangno Pharmacology Molecular PharmacologyPropranolol ConcentrationsDose Dependent KineticsHepatologyPharmacological Study	1972	233
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. Gwyn H. Evans, Alan S. Nies, David G. Shand PubMed Mammalian PhysiologyQuantitative PharmacologyPharmacotherapySystem PharmacologyExperimental Pharmacology	1973	206
The Disposition of Propranolol David G. Shand, Robert E. Rangno, Gwyn H. Evans Pharmacology PharmacotherapyExperimental PharmacologyPropranolol ExtractionMolecular PharmacologyPharmacological Study	1972	186

Page 1